President Donald Trump announced two sweeping regulations Friday aimed at lowering prescription drug prices for Americans.

The other rule would require drug makers to push rebates and discounts directly on to Medicare patients rather than to insurers and middlemen pharmacy benefit managers.

Trump came into office accusing pharmaceutical companies of “getting away with murder” and complaining that other countries whose governments set drug prices were taking advantage of Americans.

As a candidate in 2016, Trump advocated for Medicare to negotiate prices.

Many other countries have their medical systems negotiate with drug makers for lower prices, effectively making the U.S.